Received Apr 15, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| RV5 | ROTAVIRUS (ROTATEQ) | MERCK & CO. INC. | 1 | 2155638 | — |
No symptoms were reported; patient received her 1st dose ROTATEQ at 6-months of age; This spontaneous report was received from a nurse practitioner, concerning a 6-month-old patient of unknown gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 02-Apr-2026, the patient was vaccinated with the first dose of Rotavirus Vaccine, Live, Oral, Pentavalent (Rotateq), (lot #2155638 has been verified to be valid, expiration date reported and confirmed as14-Dec-2026), 2 mL, (route of administration not provided), as prophylaxis. Per label vaccine should be given at 6 weeks and not more than at 14 weeks and 6 days, the patient was 6 months (Product administered to patient of inappropriate age). No adverse event provided (No adverse event).